Cure Alliance scientists, after two years of fighting COVID-19, return to their original missions
The Cure Alliance is a boutique 501(c)(3) non-profit group of top scientists, researchers, medical doctors and innovators, plus those who support our efforts to end human suffering by developing cures for chronic, debilitating and fatal diseases.
Our #1 goal has always been to help accelerate potential cures from the laboratory to the patient’s bedside.
Today, with great urgency, our priority is to tear down the remaining barriers to curing diseases and advance well-designed, clinical trials with achievable goals.
We are also expanding our resources into the exciting emerging science of healthspan, living longer without disease.
We continue to join forces with teams around the world, sharing knowledge, advancing cures, contributing to science to help end human suffering.
A letter from The Cure Alliance President
Today The Cure Alliance is proud to announce two new partnerships that advance both halves of our mission: curing and preventing chronic, debilitating, and fatal diseases. First, we are supporting the research of Dr. Rumela Chakrabarti as she tests new ways to stop...
We did it
From an Idea to a Registrational Pathway for Islet Transplantation This milestone represents the culmination of a remarkable scientific and translational journey that began nearly a decade ago. At NobleCon in 2018, Dr. Camillo Ricordi, as a member of Noble Capital...
Eledon Pharmaceuticals Announces Submission of an Investigational New Drug (IND) Application for Islet Transplantation
Stimulated by the extremely promising preliminary results from our pilot study involving 12 patients, Eledon Pharmaceuticals has submitted an IND application to the U.S. Food and Drug Administration (FDA). This represents the first and a very important step toward...
First 5 Patients with ‘Brittle’ T1D are Insulin-Free
Breaking News from 2025 Congress of Cell Transplantation and Regenerative Medicine Society TOKYO, JAPAN, October 27, 2025 /EINPresswire.com/ -- At the 2025 Congress of the Cell Transplant and Regenerative Medicine Society Saturday, world-renowned expert Dr. Camillo...
First Three Patients with T1D Successfully Transplanted with Novel Antibody to Eliminate Harsh Anti-rejection Drug
Stunning Results of First Human Trials Presented Today in Boston at 5th Summit on Stem Cell Derived Islets MIAMI, FL, UNITED STATES, October 29, 2024 /EINPresswire.com/ — The Cure Alliance, a 501(c)(3) nonprofit, is excited to announce that three patients with type 1...
Founder’s letter to our Cure Alliance friends
Dear Friends, In recent years, The Cure Alliance (TCA) has proudly contributed to clinical trials of stem cell infusions (MSC) in severe COVID-19, and in chronic kidney disease (CKD), providing critically important information on the safety, efficacy, and mechanism of...